Gerstein HC, Branch K, Heenan L, Del Prato S, et al. Design and baseline characteristics of the AMPLITUDE-O cardiovascular outcomes trial of efpeglenatide, a weekly glucagon-like peptide-1 receptor agonist. Diabetes Obes Metab 2021;23:318-323.
PMID: 33026143